- Lobbying
- Dayle AND Cristinzio
Lobbying Arrangements Results for 'Dayle Cristinzio'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Issues Related to FDA regulation of needle-free jet administration of vaccines. |
PharmaJet
|
FOLEY HOAG LLP | |||
Details Medicare drug reimbursement |
Optimer Pharmaceuticals, Inc.
Pharmaceutical company |
FOLEY HOAG LLP | |||
Details H.R. 307, Pandemic and All Hazards Preparedness Reauthorization Act; and Implementation of Project BioShield Act. Implementation of the American Taxpayer Relief Act of 2012 Pub.L. 112240, H.R. 8 S.... |
Chimerix, Inc.
|
FOLEY HOAG LLP | |||
Details Independence at Home Program, S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017, oral health coverage for seniors, telehealth, Medicare reform |
Gary and Mary West Health Institute
|
in-house lobbying | |||
Details S. 3187 Food and Drug Administration Safety and Administration Act H.R. 5651 Food and Drug Administration Reform Act Work to educate Congress on telehealth and telemedicine issues in the Prescripti... |
Teladoc, Inc.
|
FOLEY HOAG LLP | |||
Details MODDERN Cures Act, H.R. 3091 and H.R. 3116. |
Eli Lilly and Company
|
FOLEY HOAG LLP | |||
Details Legislative and regulatory matters related to the FDA and CMS with focus on the coverage and reimbursement of novel therapeutics for the treatment of obesity |
Orexigen Therapeutics, Inc.
|
in-house lobbying | |||
Details Advocacy related to safety of vision therapies. |
Safe Vision Alliance
|
VENN STRATEGIES, LLC | |||
Details S.510 FDA Food Safety Modernization Act; H.R. 2749 Food Safety Enhancement Act of 2009; S. 3307 Healthy, Hunger-Free Kids Act of 2010; H.R. 5504 Improving Nutrition for America's Children Act. H.R.... |
Abbott Laboratories
|
FOLEY HOAG LLP | |||
Details Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act (H.R.1958); Insurance Fairn... |
American Orthotic & Prosthetic Association
|
FOLEY HOAG LLP | |||
Details Pending healthcare legislation and potential impact on the biopharmaceutical industry. Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization; HIV/AIDS research, testing an... |
GILEAD SCIENCES, INC
|
FOLEY HOAG LLP | |||
Details Nuclear Regulatory Commission requirements for beta emitters. |
Spectrum Pharmaceuticals
|
FOLEY HOAG LLP | |||
Details Legislative and regulatory matters related to the Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) with a focus on the coverage and reimbursement of novel... |
Orexigen Therapeutics, Inc.
|
FOLEY HOAG LLP | |||
Details Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Healt... |
Susan G. Komen For The Cure
Non-for-profit breast cancer patient and survivor advocacy group |
FOLEY HOAG LLP | |||
Details - Issues related to OTC drug products. - Issues related to pseudoephedrine and acetaminophen. - Issues related to the regulation of cosmetic products. - H.R. 1078, Food and Drug Administration Sa... |
McNeil Consumer Healthcare LLC
Consumer healthcare products |
FOLEY HOAG LLP | |||
Details Health care issues as they relate to the delivery of critical care services in the United States |
Roundtable on Critical Care Policy
|
VENN STRATEGIES, LLC | |||
Details -Medicare Part B and D payment for drugs -Issues related to the repeal of the non-interference clause in Part D -Implementation of Orphan Drug Act of 1983 (P.L. 97-414) and orphan drug development ... |
Sanofi US Services, Inc.
|
FOLEY HOAG LLP | |||
Details General issues related to the bio-pharmaceutical sector, innovation, patient access, health care manufacturing, and pandemic preparedness/response. Measures related to U.S. international and corpor... |
Regeneron Pharmaceuticals, Inc.
|
VENN STRATEGIES | |||
Details Legislation and other proposed policy change impacting S Corporation ESOPs. |
EMPLOYEE-OWNED S CORPORATIONS OF AMERICA
|
VENN STRATEGIES |